These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 19594422)

  • 1. Benefits of structural genomics for drug discovery research.
    Grabowski M; Chruszcz M; Zimmerman MD; Kirillova O; Minor W
    Infect Disord Drug Targets; 2009 Nov; 9(5):459-74. PubMed ID: 19594422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress of structural genomics initiatives: an analysis of solved target structures.
    Todd AE; Marsden RL; Thornton JM; Orengo CA
    J Mol Biol; 2005 May; 348(5):1235-60. PubMed ID: 15854658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unmet challenges of structural genomics.
    Chruszcz M; Domagalski M; Osinski T; Wlodawer A; Minor W
    Curr Opin Struct Biol; 2010 Oct; 20(5):587-97. PubMed ID: 20810277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural genomics and drug discovery for infectious diseases.
    Anderson WF
    Infect Disord Drug Targets; 2009 Nov; 9(5):507-17. PubMed ID: 19860716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of structural genomics: the first quindecennial.
    Grabowski M; Niedzialkowska E; Zimmerman MD; Minor W
    J Struct Funct Genomics; 2016 Mar; 17(1):1-16. PubMed ID: 26935210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based functional inference in structural genomics.
    Kim SH; Shin DH; Choi IG; Schulze-Gahmen U; Chen S; Kim R
    J Struct Funct Genomics; 2003; 4(2-3):129-35. PubMed ID: 14649297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tuberculosis structural genomics consortium: a structural genomics approach to drug discovery.
    Musa TL; Ioerger TR; Sacchettini JC
    Adv Protein Chem Struct Biol; 2009; 77():41-76. PubMed ID: 20663481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of structural proteomics on biotechnology.
    Manjasetty B; Turnbull A; Panjikar S
    Biotechnol Genet Eng Rev; 2010; 26():353-70. PubMed ID: 21415888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMR in structural genomics to increase structural coverage of the protein universe: Delivered by Prof. Kurt Wüthrich on 7 July 2013 at the 38th FEBS Congress in St. Petersburg, Russia.
    Serrano P; Dutta SK; Proudfoot A; Mohanty B; Susac L; Martin B; Geralt M; Jaroszewski L; Godzik A; Elsliger M; Wilson IA; Wüthrich K
    FEBS J; 2016 Nov; 283(21):3870-3881. PubMed ID: 27154589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The structural genomics experimental pipeline: insights from global target lists.
    O'Toole N; Grabowski M; Otwinowski Z; Minor W; Cygler M
    Proteins; 2004 Aug; 56(2):201-10. PubMed ID: 15211505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural genomics-impact on biomedicine and drug discovery.
    Weigelt J
    Exp Cell Res; 2010 May; 316(8):1332-8. PubMed ID: 20211166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selecting targets from eukaryotic parasites for structural genomics and drug discovery.
    Phan IQ; Stacy R; Myler PJ
    Methods Mol Biol; 2014; 1140():53-9. PubMed ID: 24590708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fragment screening of infectious disease targets in a structural genomics environment.
    Begley DW; Davies DR; Hartley RC; Edwards TE; Staker BL; Van Voorhis WC; Myler PJ; Stewart LJ
    Methods Enzymol; 2011; 493():533-56. PubMed ID: 21371605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Target selection for structural genomics: an overview.
    Marsden RL; Orengo CA
    Methods Mol Biol; 2008; 426():3-25. PubMed ID: 18542854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of structural genomics: expectations and outcomes.
    Chandonia JM; Brenner SE
    Science; 2006 Jan; 311(5759):347-51. PubMed ID: 16424331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural biology and drug discovery.
    Scapin G
    Curr Pharm Des; 2006; 12(17):2087-97. PubMed ID: 16796557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Seattle Structural Genomics Center for Infectious Disease (SSGCID).
    Myler PJ; Stacy R; Stewart L; Staker BL; Van Voorhis WC; Varani G; Buchko GW
    Infect Disord Drug Targets; 2009 Nov; 9(5):493-506. PubMed ID: 19594426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural genomics: bridging functional genomics and structure-based drug design.
    Buchanan SG
    Curr Opin Drug Discov Devel; 2002 May; 5(3):367-81. PubMed ID: 12058612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.